Wells Fargo
PAVM icon

Wells Fargo’s PAVmed PAVM Stock Holding History

Wells Fargo’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$267 Hold
45
– – ﹤0.01% 6573
2026
Q1 		$457 Sell
45
-10
-18% -$95 ﹤0.01% 6405
2025
Q4 		$363 Hold
55
– – ﹤0.01% 6356
2025
Q3 		$709 Buy
55
+7
+15% +$104 ﹤0.01% 6275
2025
Q2 		$867 Hold
48
– – ﹤0.01% 6324
2025
Q1 		$1.04K Sell
48
-30
-38% -$622 ﹤0.01% 6237
2024
Q4 		$1.48K Sell
78
-15
-16% -$443 ﹤0.01% 6221
2024
Q3 		$3.42K Sell
93
-37
-28% -$1.14K ﹤0.01% 5987
2024
Q2 		$3.18K Sell
130
-108
-45% -$5.38K ﹤0.01% 5945
2024
Q1 		$15.3K Sell
238
-143
-38% -$10.8K ﹤0.01% 5645
2023
Q4 		$47K Sell
381
-289
-43% -$34.1K ﹤0.01% 5299
2023
Q3 		$88.9K Sell
670
-105
-14% -$16.3K ﹤0.01% 4844
2023
Q2 		$142K Hold
775
– – ﹤0.01% 4793
2023
Q1 		$130K Sell
775
-40
-5% -$8.42K ﹤0.01% 4686
2022
Q4 		$176K Buy
815
+128
+19% +$48.3K ﹤0.01% 4243
2022
Q3 		$265K Buy
687
+372
+118% +$211K ﹤0.01% 4083
2022
Q2 		$132K Sell
315
-129
-29% -$62.3K ﹤0.01% 4486
2022
Q1 		$264K Buy
444
+88
+25% +$65.4K ﹤0.01% 4826
2021
Q4 		$394K Sell
356
-43
-11% -$93.5K ﹤0.01% 4855
2021
Q3 		$1.53M Sell
399
-12
-3% -$37.8K ﹤0.01% 3892
2021
Q2 		$1.18M Sell
411
-129
-24% -$305K ﹤0.01% 4096
2021
Q1 		$1.08M Buy
540
+50
+10% +$75.2K ﹤0.01% 4192
2020
Q4 		$468K Buy
490
+198
+68% +$169K ﹤0.01% 4567
2020
Q3 		$234K Buy
292
+176
+152% +$157K ﹤0.01% 4877
2020
Q2 		$110K Buy
+116
New +$116K ﹤0.01% 5185
2020
Q1 		– Hold
0
– – – 6628

Other funds holding PAVM

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo's PAVM Position: Q2 2026 in Review

Wells Fargo held its PAVmed (PAVM) position steady in Q2 2026 at 45 shares worth $267. The position accounts for ﹤0.01% of the portfolio, ranked #6573.

Wells Fargo first reported a position in PAVM in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.53M in Q3 2021. 19 funds tracked by Wall St. Rank hold PAVM as of Q2 2026.

  • Wells Fargo held 45 shares of PAVmed worth $267 as of Q2 2026.
  • Wells Fargo left its PAVmed share count unchanged in Q2 2026.
  • PAVmed made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6573 holding.
  • Wells Fargo first reported a position in PAVmed in Q2 2020 and has held it in 25 quarters since.
  • Wells Fargo's PAVmed position peaked at $1.53M in Q3 2021.
  • 19 funds tracked by Wall St. Rank held PAVmed as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.